AI assistant
Sending…
HORACE MANN EDUCATORS CORP /DE/ — Director's Dealing 2013
Jun 14, 2013
31760_dirs_2013-06-14_8b67c467-ab84-4d89-a993-4d1fb52dc07b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HORACE MANN EDUCATORS CORP /DE/ (HMN)
CIK: 0000850141
Period of Report: 2013-06-12
Reporting Person: Cardinal Steve (EVP & Chief Markting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-12 | Common Stock | M | 3548 | $9.04 | Acquired | 68266.093 | Direct |
| 2013-06-12 | Common Stock | S | 3548 | $25.0014 | Disposed | 64718.093 | Direct |
| 2013-06-13 | Common Stock | M | 44280 | $9.04 | Acquired | 108998.093 | Direct |
| 2013-06-13 | Common Stock | S | 44280 | $25.135 | Disposed | 64718.093 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-12 | Employee Stock Option (right to buy) | $9.04 | M | 3548 | Disposed | 2015-12-10 | Common Stock (3548) | Direct |
| 2013-06-13 | Employee Stock Option (right to buy) | $9.04 | M | 44280 | Disposed | 2015-12-10 | Common Stock (44280) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.05.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.31.
More from HORACE MANN EDUCATORS CORP /DE/
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Major Shareholding Notification
2026
May 13
Interim / Quarterly Report
2026
May 8
Earnings Release
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 30